A New Alzheimer’s Drug Offers More Questions Than Answers  The New York Times Go to News Source

Study Finds Link Between Air Pollution And Alzheimer’s Disease In Charlotte Area  WFAE Go to News Source

Roche in talks with FDA on Alzheimer’s candidate, says CEO  Reuters Go to News Source

In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug  The New York Times Go to News Source

Blood tests could help screen anticipated flood of patients seeking new Alzheimer’s drug  Science Magazine Go to News Source

Alzheimer’s Association plans in-person Walk to End Alzheimer’s  The Albany Herald Go to News Source

Alzheimers Q&A: How do you care for an alcoholic with Alzheimer’s disease?  The Advocate Go to News Source

Why Exercise Can Help Prevent Alzheimer’s  WebMD Go to News Source

Alzheimer’s disease was already terrifying. Aduhelm may actually make it worse.  Vox.comFDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectiveness  KOLDCleveland Clinic promoted Alzheimer’s drug Aduhelm before deciding to shun it  AxiosBiogen Is Still a Buy Despite Alzheimer’s Drug Concerns, Analyst Says  Barron’sSenior Living: Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works  OCRegisterView Full […]

Cognitively stimulating activities delay Alzheimer’s by 5 years  Medical News Today Go to News Source